Sachin D. Shinde

686 citations

22 papers · 507 indexed · h-index 11

Organic Chemistry top 10%
Molecular Biology
Computational Theory and Mathematics top 5%
Complementary and alternative medicine top 10%
Pharmacology

Co-authors: Rameshwar S. Cheke Umesh B. Mahajan Pankaj G. Jain Sanjay J. Surana Harun Patel Vaishali M. Patil Iqrar Ahmad Adel Kadri
Topics: Natural Antidiabetic Agents Studies (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Diverse Scientific Research Studies (3 papers)
Cited by: Complementary and alternative medicine Pharmacology Organic Chemistry
Journals: SHILAP Revista de lepidopterologíaJournal of Molecular Structure Heliyon
Partner nations: India Malaysia Indonesia

In The Last Decade

Sachin D. Shinde

20 papers receiving 492 citations

Peers

Countries citing papers authored by Sachin D. Shinde

Since Specialization

Citations

This map shows the geographic impact of Sachin D. Shinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachin D. Shinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachin D. Shinde more than expected).

Fields of papers citing papers by Sachin D. Shinde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachin D. Shinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachin D. Shinde. The network helps show where Sachin D. Shinde may publish in the future.

Co-authorship network of co-authors of Sachin D. Shinde

This figure shows the co-authorship network connecting the top 25 collaborators of Sachin D. Shinde. A scholar is included among the top collaborators of Sachin D. Shinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachin D. Shinde. Sachin D. Shinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery 2022 ·Pharmaceuticals ·Rameshwar S. Cheke,Vaishali M. Patil,Sandip D. Firke,(unknown),Iqrar Ahmad,Harun Patel,Sachin D. Shinde,Visweswara Rao Pasupuleti,Md. Imtaiyaz Hassan,Mohd Adnan,Adel Kadri,Mejdi Snoussi	83
2	Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery 2022 ·Antibiotics ·Rameshwar S. Cheke,Harun Patel,Vaishali M. Patil,Iqrar Ahmad,(unknown),Sachin D. Shinde,Adel Kadri,Mejdi Snoussi,Mohd Adnan,Prashant S. Kharkar,Visweswara Rao Pasupuleti,Prashant K. Deshmukh	51
3	Cardio-protective effect of Cocculus hirsutus in experimental hypertension in rats 2022 ·Journal of Ayurveda and Integrative Medicine ·(unknown),(unknown),(unknown),Shachindra L. Nargund,Sachin D. Shinde,(unknown)	2
4	Intranasal Drug Delivery: Novel Delivery Route for Management of Parkinson’s and Depression Neurological Disorders 2021 ·Letters in Applied NanoBioScience ·(unknown),(unknown),(unknown),(unknown),Sachin D. Shinde,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2
5	In-vivo and in-vitro evaluation of therapeutic potential of β- Carotene in diabetes 2021 ·Journal of Diabetes & Metabolic Disorders ·(unknown),(unknown),Sachin D. Shinde,(unknown)	14
6	EVALUATION OF IN VITRO ANTIOXIDANT AND IN VIVO HEPATOPROTECTIVE ACTIVITY OF BAUHINIA VARIEGATA ROOT ETHANOLIC EXTRACT AGAINST CCL4 INDUCED LIVER INJURY IN RATS 2021 ·INDIAN DRUGS ·(unknown),Sunil Jalalpure,Sachin D. Shinde,(unknown),(unknown),Shitalkumar Patil	1
7	Understanding the Dynamics of COVID-19 Outbreak: Structure, Diagnosis, Prevention and Treatment 2021 ·Anti-Infective Agents ·(unknown),Rameshwar S. Cheke,Sachin D. Shinde,(unknown),Nilesh Mahajan,Vaishali M. Patil	0
8	Abrogation of cisplatin-induced nephrotoxicity in rats and HEK-293 cell lines by formononetin: in vivo and in vitro study 2021 ·Comparative Clinical Pathology ·Sachin D. Shinde,Pankaj G. Jain,Rameshwar S. Cheke,Sanjay J. Surana,(unknown)	8
9	Studies on Formulation and Evaluation of Eudragit RS PO Based Nanoparticulate System of Aceclofenac for Ocular Delivery 2021 ·Indian Journal of Pharmaceutical Education and Research ·Sfurti Sakhare,Sachin D. Shinde,(unknown),(unknown)	2
10	Quinazoline: An update on current status against convulsions 2021 ·Journal of Molecular Structure ·Rameshwar S. Cheke,Sachin D. Shinde,(unknown),(unknown),Sanjay B. Bari	27
11	Natural Product Emerging as Potential SARS Spike Glycoproteins-ACE2 Inhibitors to Combat COVID-19 Attributed by In-Silico Investigations 2020 ·Biointerface Research in Applied Chemistry ·Rameshwar S. Cheke,(unknown),Sachin D. Shinde,(unknown),Pankaj G. Jain,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	10
12	Repurposing of Anthelmintic Drugs against SARS-CoV-2 (Mpro and RdRp): Novel Disease, Older Therapeutics 2020 ·Letters in Applied NanoBioScience ·Rameshwar S. Cheke,(unknown),Sachin D. Shinde,(unknown),Pankaj G. Jain,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2
13	Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences 2020 ·Natural Products and Bioprospecting ·(unknown),(unknown),Rameshwar S. Cheke,Sachin D. Shinde	160
14	The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences 2020 ·Advances in Traditional Medicine ·Sachin D. Shinde,Rameshwar S. Cheke,(unknown),Pankaj G. Jain,(unknown)	8
15	Bioactive role of plant stress hormone methyl jasmonate against lipopolysaccharide induced arthritis 2020 ·Heliyon ·(unknown),Sagar B. Wankhede,(unknown),Sachin D. Shinde	5
16	The possible antioxidant capabilities of formononetin in guarding against streptozotocin-induced diabetic nephropathy in rats 2020 ·SHILAP Revista de lepidopterología ·Pankaj G. Jain,(unknown),(unknown),Sachin D. Shinde,Sanjay J. Surana	13
17	Disulfiram and Its Copper Chelate Attenuate Cisplatin-Induced Acute Nephrotoxicity in Rats Via Reduction of Oxidative Stress and Inflammation 2019 ·Biological Trace Element Research ·(unknown),Umesh B. Mahajan,Kalpesh R. Patil,Harun Patel,Sachin D. Shinde,Sameer N. Goyal,Sateesh Belemkar,Shreesh Ojha,Chandragouda R. Patil	34
18	Cardioprotective role of FA against isoproterenol induced cardiac toxicity 2018 ·Molecular Biology Reports ·Pankaj G. Jain,Umesh B. Mahajan,Sachin D. Shinde,Sanjay J. Surana	46
19	A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats 2018 ·Cardiovascular Toxicology ·(unknown),Umesh B. Mahajan,Sachin D. Shinde,Subhajit Chatterjee,(unknown),(unknown),Shreesh Ojha,Sameer N. Goyal,Chanakya Nath Kundu,Chandragouda R. Patil	23
20	Evaluation of Hypolipidemic Potential of a Polyherbal Formulation in Experimental Rats 2018 ·Research Journal of Pharmacy and Technology ·(unknown),(unknown),(unknown),Sachin D. Shinde,(unknown),Ashwin Porwal,(unknown)	4

About Sachin D. Shinde

Sachin D. Shinde is a scholar working on Drug Discovery, Biochemistry and Pharmaceutical Science, having authored 22 papers that have together received 507 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Diverse Scientific Research Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (63 citations), Pharmacology (54 citations) and Organic Chemistry (161 citations). Sachin D. Shinde has collaborated with scholars based in India, Malaysia and Indonesia. Frequent co-authors include Rameshwar S. Cheke, Umesh B. Mahajan, Pankaj G. Jain, Sanjay J. Surana, Harun Patel, Vaishali M. Patil, Iqrar Ahmad, Adel Kadri, Mohd Adnan and Visweswara Rao Pasupuleti. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Molecular Structure and Heliyon.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact